Lawrence Fialkow
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Blood Transfusion | 2 | 2009 | 59 |
Why?
|
Leukapheresis | 1 | 2010 | 17 |
Why?
|
Acute Lung Injury | 1 | 2010 | 12 |
Why?
|
Vascular Diseases | 1 | 2010 | 60 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2002 | 58 |
Why?
|
Platelet Transfusion | 2 | 2010 | 20 |
Why?
|
ABO Blood-Group System | 2 | 2009 | 26 |
Why?
|
Pentoxifylline | 3 | 2003 | 15 |
Why?
|
Immunosuppressive Agents | 3 | 2002 | 102 |
Why?
|
Interleukin-10 | 3 | 2002 | 38 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2004 | 5 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2003 | 78 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2011 | 14 |
Why?
|
Pulmonary Circulation | 1 | 2010 | 42 |
Why?
|
Postoperative Hemorrhage | 1 | 2011 | 19 |
Why?
|
Health Plan Implementation | 1 | 2010 | 20 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 29 |
Why?
|
Trans-Activators | 2 | 2003 | 113 |
Why?
|
Hospital Mortality | 1 | 2011 | 60 |
Why?
|
Length of Stay | 1 | 2011 | 166 |
Why?
|
Heart-Assist Devices | 1 | 2009 | 16 |
Why?
|
HLA Antigens | 1 | 2009 | 38 |
Why?
|
DNA-Binding Proteins | 2 | 2003 | 204 |
Why?
|
Incidence | 1 | 2010 | 336 |
Why?
|
Retrospective Studies | 2 | 2010 | 653 |
Why?
|
Mice, Inbred NOD | 5 | 2002 | 24 |
Why?
|
Time Factors | 3 | 2004 | 896 |
Why?
|
Postoperative Complications | 1 | 2010 | 305 |
Why?
|
Autoimmunity | 1 | 2005 | 27 |
Why?
|
Recurrence | 2 | 2004 | 261 |
Why?
|
Propylene Glycols | 1 | 2003 | 2 |
Why?
|
Islets of Langerhans | 4 | 2003 | 26 |
Why?
|
Insulin | 5 | 2002 | 129 |
Why?
|
Gene Therapy | 1 | 2005 | 89 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2003 | 36 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 34 |
Why?
|
Gene Transfer Techniques | 1 | 2002 | 59 |
Why?
|
Viral Proteins | 1 | 2002 | 71 |
Why?
|
Mice | 6 | 2002 | 623 |
Why?
|
Cytokines | 3 | 2002 | 207 |
Why?
|
STAT4 Transcription Factor | 2 | 2003 | 2 |
Why?
|
Humans | 4 | 2003 | 1856 |
Why?
|
Graft Survival | 2 | 2004 | 74 |
Why?
|
Female | 6 | 2002 | 1643 |
Why?
|
Random Allocation | 2 | 2003 | 160 |
Why?
|
Mice, SCID | 2 | 2002 | 61 |
Why?
|
Animals | 6 | 2002 | 1031 |
Why?
|
Genetic Vectors | 2 | 2002 | 139 |
Why?
|
Blood Component Transfusion | 1 | 2011 | 8 |
Why?
|
Plasma | 1 | 2011 | 25 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 13 |
Why?
|
Male | 5 | 2002 | 1553 |
Why?
|
Transfection | 2 | 2002 | 237 |
Why?
|
Leukocyte Reduction Procedures | 1 | 2009 | 8 |
Why?
|
Immunohistochemistry | 2 | 2003 | 355 |
Why?
|
Isoantibodies | 1 | 2009 | 25 |
Why?
|
Heart Transplantation | 1 | 2009 | 44 |
Why?
|
Mice, Inbred C57BL | 2 | 2003 | 318 |
Why?
|
Leukocytes | 1 | 2009 | 94 |
Why?
|
Aged | 2 | 2009 | 988 |
Why?
|
Middle Aged | 2 | 2009 | 1161 |
Why?
|
Transplantation, Isogeneic | 1 | 2005 | 21 |
Why?
|
Adult | 2 | 2009 | 1317 |
Why?
|
Adenoviridae | 1 | 2005 | 60 |
Why?
|
Mice, Congenic | 1 | 2004 | 3 |
Why?
|
Interleukin-12 | 1 | 2003 | 27 |
Why?
|
Streptozocin | 1 | 2003 | 18 |
Why?
|
Lymphocyte Count | 1 | 2003 | 38 |
Why?
|
Sphingosine | 1 | 2003 | 16 |
Why?
|
Inflammation Mediators | 1 | 2004 | 56 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 53 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 137 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 94 |
Why?
|
Adoptive Transfer | 1 | 2002 | 16 |
Why?
|
Injections, Intramuscular | 1 | 2002 | 43 |
Why?
|
Transgenes | 1 | 2002 | 56 |
Why?
|
Interleukin-4 | 1 | 2003 | 62 |
Why?
|
Th1 Cells | 1 | 2002 | 33 |
Why?
|
Dependovirus | 1 | 2002 | 29 |
Why?
|
Th2 Cells | 1 | 2002 | 36 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 224 |
Why?
|
T-Lymphocytes | 1 | 2005 | 182 |
Why?
|
Interferon-gamma | 1 | 2003 | 133 |
Why?
|
Recombination, Genetic | 1 | 2002 | 78 |
Why?
|
Glucose | 1 | 2003 | 120 |
Why?
|
Spleen | 1 | 2002 | 129 |
Why?
|
Phosphorylation | 1 | 2003 | 224 |
Why?
|
Disease Models, Animal | 1 | 2004 | 349 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 431 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 210 |
Why?
|
Apoptosis | 1 | 2004 | 265 |
Why?
|
Gene Expression Regulation | 1 | 2002 | 277 |
Why?
|
Signal Transduction | 1 | 2003 | 313 |
Why?
|
